Marius Patberg

Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies.

H. de Vries, L. Heitman, B. Wünsch, 2018, European journal of medicinal chemistry.

Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists.

L. Heitman, T. Budde, O. Koch, 2021, European journal of medicinal chemistry.

Optimized synthesis and pharmacological evaluation of HCN channel inhibitor EC18

H. Wiendl, S. Meuth, T. Budde, 2023, Archiv der Pharmazie.